Ready to play
Ready to play
European stocks rose today, approaching their highest levels in a week, supported by a strong performance in the healthcare sector, which increased by 1.6%. Leading the gains was Genmab, after a study showed that its treatment for leukemia reduces the risk of death and disease progression, causing its stock to jump by 7.6%. Results from other sectors, such as TechnoPro, also contributed to the market’s strength. Meanwhile, Eurozone bond yields declined after a prior surge, helping to underpin the stock markets despite political and financial uncertainty. Investors are also awaiting key economic data on spending and consumption in the region and the UK.
Notice: This Is an AI-Generated Summary
Comments (0)